- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Picker wins ruling in ISO case
Picker International hopes a federal court judge's ruling thismonth has ended its eight-year legal battle with independent serviceorganization Imaging Equipment Services (IES) of Pittsburgh. Picker filed the litigation in 1987, accusing IES of
Picker International hopes a federal court judge's ruling thismonth has ended its eight-year legal battle with independent serviceorganization Imaging Equipment Services (IES) of Pittsburgh.
Picker filed the litigation in 1987, accusing IES of improperuse of service software and other charges. IES in turn chargedPicker with antitrust violations relating to scanner service.
Picker won a summary judgment ruling last year that threw outmany of the IES accusations (SCAN 6/15/94). In a ruling this month,U.S. District Court Judge Mark Wolf rejected the last of the ISO'scharges relating to intellectual property and issued a stingingrebuke to IES.
In a 73-page opinion, Wolf said IES "engaged in a relentlessand extensive campaign to misappropriate Picker's legally protectedintellectual property."
Wolf ordered IES to return or destroy Picker diagnostic softwareand service and repair documentation in its possession and permanentlyenjoined IES from violating Picker copyrights or misappropriatingPicker trade secrets. The judge appointed a monitor to ensurethat IES complies with the court's order.
A Picker spokesperson said the Cleveland vendor hopes thatWolf's ruling will be the last word on the case. IES plans toappeal the ruling to the U.S. Court of Appeals, according to IEScounsel Bill West.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
